百字明咒注音：南无金刚萨埵菩萨摩诃萨
om │ ban-ze^re sa-due-sa-ma-ya │ ma-nu-ba-la-ya │
唵 │ 班 杂 萨 埵 萨 玛 雅│ 玛 努 巴 拉 雅│
ben-ze^re-sa-due-dei-no-ba-di-chan-zhi-duo-mei-ba-wa │
班 杂 萨 埵 得 诺 巴 地 茶 智 多 美 巴 瓦 │
su-duo-ka^yo-mei-ba-wa │ su-bo-ka^y
om │ ban-ze^re sa-due-sa-ma-ya │ ma-nu-ba-la-ya │
唵 │ 班 杂 萨 埵 萨 玛 雅│ 玛 努 巴 拉 雅│
ben-ze^re-sa-due-dei-no-ba-di-chan-zhi-duo-mei-ba-wa │
班 杂 萨 埵 得 诺 巴 地 茶 智 多 美 巴 瓦 │
su-duo-ka^yo-mei-ba-wa │ su-bo-ka^y
百字明咒注音：南无金刚萨埵菩萨摩诃萨
om │ ban-ze^re sa-due-sa-ma-ya │ ma-nu-ba-la-ya │
唵 │ 班 杂 萨 埵 萨 玛 雅│ 玛 努 巴 拉 雅│
ben-ze^re-sa-due-dei-no-ba-di-chan-zhi-duo-mei-ba-wa │
班 杂 萨 埵 得 诺 巴 地 茶 智 多 美 巴 瓦 │
su-duo-ka^yo-mei-ba-wa │ su-bo-ka^y
om │ ban-ze^re sa-due-sa-ma-ya │ ma-nu-ba-la-ya │
唵 │ 班 杂 萨 埵 萨 玛 雅│ 玛 努 巴 拉 雅│
ben-ze^re-sa-due-dei-no-ba-di-chan-zhi-duo-mei-ba-wa │
班 杂 萨 埵 得 诺 巴 地 茶 智 多 美 巴 瓦 │
su-duo-ka^yo-mei-ba-wa │ su-bo-ka^y
美国FDA“下架”老款单价（一价）新冠疫苗（包括莫德纳一价新冠疫苗和辉瑞-BioNTech一价新冠疫苗）。
详见：https://t.cn/A6NImOHj
FDA NEWS RELEASE
Coronavirus (COVID-19) Update: FDA Authorizes Changes to Simplify Use of Bivalent mRNA COVID-19 Vaccines
For Immediate Release:
April 18, 2023
Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule for most individuals. This action includes authorizing the current bivalent vaccines (original and omicron BA.4/BA.5 strains) to be used for all doses administered to individuals 6 months of age and older, including for an additional dose or doses for certain populations. The monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines are no longer authorized for use in the United States.
详见：https://t.cn/A6NImOHj
FDA NEWS RELEASE
Coronavirus (COVID-19) Update: FDA Authorizes Changes to Simplify Use of Bivalent mRNA COVID-19 Vaccines
For Immediate Release:
April 18, 2023
Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule for most individuals. This action includes authorizing the current bivalent vaccines (original and omicron BA.4/BA.5 strains) to be used for all doses administered to individuals 6 months of age and older, including for an additional dose or doses for certain populations. The monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines are no longer authorized for use in the United States.
✋热门推荐